HIV-envelope protein-specific DARPins (Population council/University of Zurich)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameHIV-envelope protein-specific DARPins (Population council/University of Zurich)
Drug Alias NameHIV-envelope protein-specific designed ankyrin repeat proteins (Population council/University of Zurich)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionTransmembrane glycoprotein gp41 modulatorsHIV envelope protein gp120 modulators
TargetsHIV envelope protein gp120Transmembrane glycoprotein gp41
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity of Zurich
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of ZurichPopulation Council, Inc
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A